245 results on '"Sentani, K."'
Search Results
2. The transcribed-ultraconserved regions in prostate and gastric cancer: DNA hypermethylation and microRNA-associated regulation
3. Correction: Signal peptidase complex 18, encoded by SEC11A, contributes to progression via TGF-α secretion in gastric cancer
4. Signal peptidase complex 18, encoded by SEC11A, contributes to progression via TGF-α secretion in gastric cancer
5. Clinicopathological characteristics of upper tract urothelial cancer with loss of immunohistochemical expression of mismatch repair proteins
6. Transition of ANXA10 expression is a useful diagnostic and prognostic marker in upper tract urothelial carcinoma
7. Recurrence and progression free survival of intermediate risk NMIBC: The impact of conditional evaluation and sub-classification
8. Kdm6a deficiency activates inflammatory pathways, promotes M2 macrophage polarization and causes bladder cancer with p53 dysfunction
9. KIFC1 inhibitor CW069 induces apoptosis and reverses resistance to docetaxel in prostate cancer
10. Parallels between immunohistochemical classification of upper and lower tract urothelial carcinoma using markers of urothelial differentiation
11. Accurate clinical T3 staging by a computed tomography scoring system is an independent preoperative predictor of survival in patients with urothelial carcinoma of the ureter
12. PCDHB9 promotes resistance to bicalutamide and is associated with the survival of prostate cancer patients
13. Transcribed ultraconserved region Uc.63+ promotes resistance to docetaxel through AR signaling and a promising serum biomarker for docetaxel treatment in prostate cancer
14. Warty gastric cancer with polypoid metastases to the gallbladder and urinary bladder
15. Prognostic impact of immunohistochemical classification of bladder cancer according to luminal (Uroplakin III) and basal (Cytokeratin 5/6) markers
16. PT367 - Accurate clinical T3 staging by a computed tomography scoring system is an independent preoperative predictor of survival in patients with urothelial carcinoma of the ureter
17. 851 - KIFC1 inhibitor CW069 induces apoptosis and reverses resistance to docetaxel in prostate cancer
18. 731 - Parallels between immunohistochemical classification of upper and lower tract urothelial carcinoma using markers of urothelial differentiation
19. 260 - PCDHB9 promotes resistance to bicalutamide and is associated with the survival of prostate cancer patients
20. KRAS mutation leads to decreased expression of regulator of calcineurin 2, resulting in tumor proliferation in colorectal cancer
21. 110 Combination therapy using molecular-targeted drugs inhibiting platelet-derived growth factor receptors in the tumor microenvironment of renal cell carcinoma
22. 121 TSPAN8 expression in renal cell carcinoma is a poor prognostic factor and a novel therapeutic target
23. The transcribed-ultraconserved regions in prostate and gastric cancer: DNA hypermethylation and microRNA-associated regulation
24. 111 - Transcribed ultraconserved region Uc.63+ promotes resistance to docetaxel through AR signaling and a promising serum biomarker for docetaxel treatment in prostate cancer
25. Resistin-like molecule β is abundantly expressed in foam cells and is involved in atherosclerosis development
26. 16 Comparison of clinicopathological features and prognosis in prostate cancer between atomic bomb survivors and control patients
27. 387 - Prognostic impact of immunohistochemical classification of bladder cancer according to luminal (Uroplakin III) and basal (Cytokeratin 5/6) markers
28. Signal peptidase complex 18, encoded by SEC11A, contributes to progression via TGF-α secretion in gastric cancer
29. Upregulation of HOXA10 in gastric cancer with the intestinal mucin phenotype: reduction during tumor progression and favorable prognosis
30. 254 DSC2 IS A NEW IMMUNOHISTOCHEMICAL MARKER INDICATIVE OF SQUAMOUS CELL CARCINOMA COMPONENT IN URINARY BLADDER CANCER AND A VALUABLE PROGNOSTIC FACTOR
31. Follicular Lymphoma of the Duodenum: A Clinicopathologic Analysis of 26 Cases
32. Molecular Pathobiology of Gastric Cancer
33. ALKR1275Qperturbs extracellular matrix, enhances cell invasion and leads to the development of neuroblastoma in cooperation with MYCN
34. Analysis of anti-tumor effect and mechanism of GLS1 inhibitor CB-839 in colorectal cancer using a stroma-abundant tumor model.
35. Relationship Between Clinical Parameters and Histological Features of Epicardial Adipose Tissue and Aortic Valve Calcification Assessed on Computed Tomography.
36. Distribution and Clinicopathological Features of Mott Cells (Plasma Cells Containing Russell Bodies) in Gastric Cancer: Presence of Mott Cells Is Associated with Favorable Prognosis.
37. IQ Motif Containing GTPase-Activating Protein 3 Is Associated with Cancer Stemness and Survival in Pancreatic Ductal Adenocarcinoma.
38. Kinesin Family Member B18 Is Related to Gastric Mucin Phenotype and Contributes to Gastric Cancer Progression by Regulating Epithelial-Mesenchymal Transition.
39. No significant association between non-Helicobacter pylori Helicobacter infection with gastritis-related indices and gastric cancer.
40. MCM4 expression is associated with high-grade histology, tumor progression and poor prognosis in urothelial carcinoma.
41. Clinicopathological significance of TUBB3 in upper tract urothelial carcinoma and possible application in urine cytology.
42. Dual immunocytochemical staining of annexin A10 and p53 in low-grade and papillary urothelial carcinoma contributes to improvement of diagnostic accuracy in urine cytology.
43. The Efficacy of Neoadjuvant Gemcitabine and Cisplatin Chemotherapy for cT3N0M0 Upper Tract Urothelial Carcinoma: The Impact of Tumor Location.
44. Synchronous gastric MALT lymphoma and gastric adenocarcinoma of fundic gland type arising from a hamartomatous inverted polyp in a Helicobacter pylori naive patient.
45. Comprehensive Analysis of Gene Expression Profiling to Explore Predictive Markers for Eradication Therapy Efficacy against Helicobacter pylori -Negative Gastric MALT Lymphoma.
46. Minichromosome Maintenance 4 Is Associated with Cancer Stemness and Poor Survival of Patients with Gastric Cancer.
47. Essential Roles of TDO2 in Gastric Cancer: TDO2 Is Associated with Cancer Progression, Patient Survival, PD-L1 Expression, and Cancer Stem Cells.
48. Protocadherin B9 Is Associated with Human Esophageal Squamous Cell Carcinoma Progression.
49. ANXA10 Expression Is Inversely Associated with Tumor Stage, Grade, and TP53 Expression in Upper and Lower Urothelial Carcinoma.
50. Expression of kinesin family member C1 in pancreatic ductal adenocarcinoma affects tumor progression and stemness.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.